1-7 of 7
Maria Luisa Pioltelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pomalidomide, Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Lenalidomide and Anti-CD38 Monoclonal Antibodies: A Multicentric Italian Retrospective Study

Carmine Liberatore, Paola Tacchetti, Concetta Conticello, Gregorio Barila, Elisabetta Antonioli, Angelo Belotti, Anna Maria Cafro, Laura Paris, Velia Bongarzoni, Massimo Gentile, Matteo DA VIA, Barbara Gamberi, Sara Pezzatti, Fabrizio Ciambelli, Mariagrazia Garzia, Ombretta Annibali, Francesca Fazio, Giusy Antolino, Nicola Sgherza, Francesca Farina, Annalisa Citro, Monica Galli, Vittorio Del Fabro, Claudio Salvatore Cartia, Francesca Fioritoni, Katia Mancuso, Irene Attucci, Maria Luisa Pioltelli, Michele Puppi, Sofia Terlizzi, Chiara Lisi, Virginia Valeria Ferretti, Massimo Offidani, Maria Teresa Petrucci, Silvia Mangiacavalli
Journal: Blood
Blood (2024) 144 (Supplement 1): 5153.
https://doi.org/10.1182/blood-2024-204021
Published: 2024
Journal Articles

Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up

Maria Luisa Pioltelli, MD, Ester Pungolino, Mariella D'adda, MD, Chiara Elena, MD, Lorenza Maria Borin, MDcal doctor, Alessandra Perego, MD, Alessandra Iurlo, Alessandra Trojani, PhD, Mauro Turrini, MD, Marianna Caramella, MD, Pierangelo Spedini, MD, Simona Malato, MD, Francesco Spina, MD, Salvatore Artale, MD, Mariacristina Carraro, Nicola Orofino, MD, Michela Anghilieri, MD, Mirko Farina, MD, Maria Luisa Latargia, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli
Journal: Blood
Blood (2018) 132 (Supplement 1): 5435.
https://doi.org/10.1182/blood-2018-99-113496
Published: 2018
Journal Articles

Jak-2 and Nfkbia G ene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data

Ester Pungolino, Mariella D'adda, MD, Alessandra Trojani, PhD, Alessandra Perego, MD, Chiara Elena, MD, Alessandra Iurlo, Simona Malato, MD, Mauro Turrini, MD, Gabriella De Canal, PhD, Lorenza Borin, MD, Milena Lodola, PhD, Marianna Caramella, MD, Salvatore Artale, MD, Francesco Spina, MD, Maria Luisa Latargia, MD, Michela Anghilieri, MD, Pierangelo Spedini, MD, Mariacristina Carraro, Barbara Di Camillo, Doriana Gramegna, MD, Maria Luisa Pioltelli, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli
Journal: Blood
Blood (2018) 132 (Supplement 1): 5118.
https://doi.org/10.1182/blood-2018-99-113273
Published: 2018
Journal Articles

Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia

Ester Pungolino, Mariella D'adda, Alessandra Perego, MD, Ester Maria Orlandi, MD, Mauro Turrini, MD, Lorenza Maria Borin, MD, Alessandra Iurlo, MD PhD, Salvatore Artale, Maria Luisa Latargia, MD, Michela Anghilieri, MD, Simona Malato, MD, Alessandra Trojani, Francesco Spina, MD, Carraro Maria Cristina, MD, Maria Luisa Pioltelli, MD, Chiara Elena, Cristina Bucelli, MD, Pierangelo Spedini, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2889.
https://doi.org/10.1182/blood.V130.Suppl_1.2889.2889
Published: 2017
Journal Articles

The REL-Protocol PhilosoPhi34 - an Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia (CML) Patients - Confirms Early Clearance of Bone Marrow CD34+/Lin-Ph+ Cells

Ester Pungolino, MD, Gabriella De Canal, Mariella D'adda, MD, Alessandra Perego, MD, Mauro Turrini, MD, Ester Maria Orlandi, MD, Alessandra Trojani, PhD, Lorenza Borin, MD, Alessandra Iurlo, MD, Maria Luisa Latargia, MD, Simona Malato, MD, Maria Cristina Carraro, MD, Stefania Brusorio, Chiara Elena, MD, Francesco Spina, MD, Milena Lodola, Salvatore Artale, MD, Michela Anghilieri, MD, Cristina Bucelli, MD, Maria Luisa Pioltelli, MD, Silvia Cantoni, MD, Giuseppe Rossi, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2016) 128 (22): 3080.
https://doi.org/10.1182/blood.V128.22.3080.3080
Published: 2016
Journal Articles

REL-Protocol PhilosoPhi34: An Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia Patients, to Study the Disappearance of CD34+/Lin-Ph+ Cells from Bone Marrow during Treatment. Preliminary Data

Ester Pungolino, MD, Giuseppe Rossi, MD, Maria Angela Mura, Alessandra Perego, MD, Ester Maria Orlandi, MD, Mauro Turrini, MD, Lorenza Borin, MD, Maria Adele Capucci, MD, Alessandra Iurlo, MD PhD, Alessandra Trojani, PhD, Mariella D'Adda, MD, Francesco Spina, MD, Gabriella De Canal, Maria Luisa Pioltelli, Maria Luisa Latargia, MD, Sergio Pauli, MD, Chiara Elena, MD, Stefania Brusorio, Francesco Lanza, MD, Simona Malato, MD, Michela Anghilieri, MD, Maria C Carraro, MD, Enrica Morra, MD, Roberto Cairoli, MD
Journal: Blood
Blood (2015) 126 (23): 1597.
https://doi.org/10.1182/blood.V126.23.1597.1597
Published: 2015
Journal Articles

Invasive Fungal Infections (IFI) In Lymphoproliferative Disorders: Epidemiology, Outcome and Prognostic Factors

Maria Luisa Pioltelli, Annamaria Nosari, Marta Riva, Laura Marbello, Laura Paris, Alessandra Tedeschi, Francesca Ricci, Eleonora Vismara, Speziale Valentina, Chiara Rusconi, Vittorio Ruggero Zilioli, Cristina Gabutti, Alfredo Molteni, Rosa Greco, Antonino Greco, Emanuele Ravano, Enrica Morra
Journal: Blood
Blood (2011) 118 (21): 4959.
https://doi.org/10.1182/blood.V118.21.4959.4959
Published: 2011